Medical Countermeasures Stem Cell Research Gives New Clues on Ebola Virus Damage to Organs by Global Biodefense Staff September 9, 2022
Medical Countermeasures NIH Begins Clinical Trial of Intradermal Monkeypox Vaccine Delivery to Expand Supply by Global Biodefense Staff September 8, 2022
Industry News Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States by Global Biodefense Staff September 7, 2022
Industry News Arcturus Awarded $63.2M to Advance Self-amplifying mRNA Vaccine for Pandemic Influenza Response by Global Biodefense Staff August 31, 2022
Medical Countermeasures New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections by Global Biodefense Staff July 17, 2022
Medical Countermeasures Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination by Global Biodefense Staff July 16, 2022
Medical Countermeasures US Starts Clinical Trial for mRNA Nipah Virus Vaccine by Global Biodefense Staff July 11, 2022
Medical Countermeasures Targeting Poxviruses with Messenger RNA Technology by Global Biodefense Staff July 11, 2022
Medical Countermeasures US Begins Phase 1 Clinical Trial of Universal Flu Vaccine by Global Biodefense Staff June 28, 2022
Medical Countermeasures UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control by Global Biodefense Staff June 21, 2022
Industry News Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs by Global Biodefense Staff June 20, 2022
Medical Countermeasures Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine by Global Biodefense Staff May 30, 2022
Industry News Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors by Global Biodefense Staff May 26, 2022
Medical Countermeasures New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs by Global Biodefense Staff April 10, 2022
Funding News NIH Awards $3M Grant to Albany Med for Plague Vaccine Development by Global Biodefense Staff April 8, 2022
Medical Countermeasures Troubling Trends in Physician Vaccine Confidence in the United States by Global Biodefense Staff April 5, 2022
Medical Countermeasures Northwestern University Researchers Develop Nanoparticle Vaccine Platform by Global Biodefense Staff March 22, 2022
Medical Countermeasures Antibody Shows Promise for Developing Hantavirus Treatment by Global Biodefense Staff March 22, 2022
CBRNE CounterACT: U.S. Funding Early Stage Drug Discovery of Countermeasures Against Chemical Threats by Global Biodefense Staff March 21, 2022
Medical Countermeasures New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines by Global Biodefense Staff March 19, 2022
